Insider Transactions
| Date | Name | Title | Type | Filing | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Nov 06, 2009 | Corporate Controller | Initial Statement of Beneficial Ownership of Securities | Form 3 | -- | -- | -- | |
| Nov 06, 2009 | Corporate Controller | Initial Statement of Beneficial Ownership of Securities | Form 3 | -- | -- | -- | |
| Nov 06, 2009 | Corporate Controller | Initial Statement of Beneficial Ownership of Securities | Form 3 | -- | -- | -- | |
| Jun 18, 2013 | Chief Scientific Officer | Grant, award or other acquisition pursuant to Rule 16b-3(d) | Form 4 | 100,000 | -- | 100,000 | |
| Jan 28, 2013 | Chief Scientific Officer | Grant, award or other acquisition pursuant to Rule 16b-3(d) | Form 4 | 100,000 | -- | 100,000 | |
| Jun 04, 2012 | Chief Scientific Officer | Grant, award or other acquisition pursuant to Rule 16b-3(d) | Form 4 | 80,000 | -- | 80,000 | |
| Feb 15, 2012 | Chief Scientific Officer | Grant, award or other acquisition pursuant to Rule 16b-3(d) | Form 4 | 80,000 | -- | 80,000 | |
| Jun 16, 2011 | Chief Scientific Officer | Grant, award or other acquisition pursuant to Rule 16b-3(d) | Form 4 | 85,000 | -- | 85,000 | |
| Jan 19, 2011 | Chief Scientific Officer | Grant, award or other acquisition pursuant to Rule 16b-3(d) | Form 4 | 50,000 | -- | 50,000 | |
| Jun 15, 2010 | Chief Scientific Officer | Grant, award or other acquisition pursuant to Rule 16b-3(d) | Form 4 | 30,000 | -- | 30,000 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.